The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.
about
Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factorsAPOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's diseasePlasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.Plasma proteins predict conversion to dementia from prodromal diseaseRegulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men.Changes of Cerebrospinal Fluid Peptides due to Tauopathy.A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.CSF Apo-E levels associate with cognitive decline and MRI changesFibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation.Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.Cholinesterases and the fine line between poison and remedy.Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease.Soluble Aβ42 Acts as Allosteric Activator of the Core Cholinergic Enzyme Choline Acetyltransferase
P2860
Q28576453-54523C90-2EE6-4D02-ABED-762BAE7CC256Q29416986-AC0EEDC2-82B3-4B86-B24C-5E5B2C279320Q30497749-45B1C753-6421-4EE0-B95A-FC90FE2852FEQ34305083-50EC58AD-8AE2-4E2F-990C-3766569D2FB8Q34556953-D8BC91BB-F576-4DFA-9298-86BF05A9A09DQ34804797-5D94C0C3-222A-48C1-9FF0-9B2EBA39377DQ36349870-A96FC351-6D4C-4B4F-A196-104C7B716FBCQ36357894-17BDAD28-29B4-4728-8F25-65FA35AB1C00Q37070395-B64F086B-CEEE-4F46-B783-E23571BEC2C4Q37104891-7B5F2331-03F9-4079-9552-C98E08DC9D00Q37615967-ECDB3638-8B31-4ED3-A2F9-4DB6DB306A9AQ37705204-AB0C1F28-4C53-4280-9183-8CCF1E707953Q38967438-F90EE000-4AF9-410F-A9C0-AD8ACD54005BQ39307470-05BA00EB-93C6-43F9-AB8F-FA8884286E3BQ50152965-C51D6E33-6734-42EA-9D8E-2683D3377932Q50563445-11DC1843-77CC-45F5-ACD6-44D3F69960B3Q53091166-7A7C7FC7-E50B-49C7-A142-56FA9EDBB053Q57110843-8C800990-2A2B-4971-A187-ED61D5C53C88
P2860
The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The apolipoprotein E ε4 allele ...... on with butyrylcholinesterase.
@en
The apolipoprotein E ε4 allele ...... on with butyrylcholinesterase.
@nl
type
label
The apolipoprotein E ε4 allele ...... on with butyrylcholinesterase.
@en
The apolipoprotein E ε4 allele ...... on with butyrylcholinesterase.
@nl
prefLabel
The apolipoprotein E ε4 allele ...... on with butyrylcholinesterase.
@en
The apolipoprotein E ε4 allele ...... on with butyrylcholinesterase.
@nl
P2093
P50
P1476
The apolipoprotein E ε4 allele ...... on with butyrylcholinesterase.
@en
P2093
Chelenk Kamil
Hiba Ahmed
Negar Modiri
Niels Andreasen
Souad Baza
P304
P356
10.1016/J.NEUROBIOLAGING.2009.07.015
P577
2009-08-26T00:00:00Z